TrialRadiation oncology (London, England)2021

Gastrointestinal and genitourinary toxicity profiles of metformin versus placebo in men with prostate cancer receiving prostate radiotherapy: interim toxicity results of a double-blinded, multicenter, phase II randomized controlled trial.

Julian O Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.